- Home
- EVF vs COYA Comparison
EVF vs COYA Comparison
Compare EVF & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- COYA
- Stock Information
- Founded
- EVF 1998
- COYA 2020
- Country
- EVF United States
- COYA United States
- Employees
- EVF N/A
- COYA N/A
- Industry
- EVF Investment Managers
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- COYA Health Care
- Exchange
- EVF Nasdaq
- COYA Nasdaq
- Market Cap
- EVF 101.0M
- COYA 107.0M
- IPO Year
- EVF N/A
- COYA 2022
- Fundamental
- Price
- EVF $5.54
- COYA $5.67
- Analyst Decision
- EVF
- COYA Strong Buy
- Analyst Count
- EVF 0
- COYA 4
- Target Price
- EVF N/A
- COYA $16.50
- AVG Volume (30 Days)
- EVF 93.3K
- COYA 112.8K
- Earning Date
- EVF 01-01-0001
- COYA 11-05-2025
- Dividend Yield
- EVF 10.68%
- COYA N/A
- EPS Growth
- EVF N/A
- COYA N/A
- EPS
- EVF 0.94
- COYA N/A
- Revenue
- EVF N/A
- COYA $423,452.00
- Revenue This Year
- EVF N/A
- COYA N/A
- Revenue Next Year
- EVF N/A
- COYA N/A
- P/E Ratio
- EVF $6.74
- COYA N/A
- Revenue Growth
- EVF N/A
- COYA N/A
- 52 Week Low
- EVF $5.20
- COYA $4.65
- 52 Week High
- EVF $6.84
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- EVF 46.38
- COYA 37.32
- Support Level
- EVF $5.48
- COYA $6.05
- Resistance Level
- EVF $5.60
- COYA $6.53
- Average True Range (ATR)
- EVF 0.04
- COYA 0.43
- MACD
- EVF 0.00
- COYA -0.10
- Stochastic Oscillator
- EVF 50.00
- COYA 19.87
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.